Bio-Rad Laboratories
S&P 400
$369.32
+0.15%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.17.
- Return on equity is moderate at 10.6%.
- Net profit margin is strong at 29.4%.
- Current assets comfortably cover current liabilities (current ratio 5.62).
!Watch-points
- Thin interest cover: operating profit covers interest only about 1 times.
- Return on capital employed is on the lower side at 0.5%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
3.55
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Piotroski F-ScoreModerate
4 / 8
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 8 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$9.87B
Current Price$ 369.32
High / Low$ 396.23 / 236.73
Stock P/E45.03903
Book Value$ 267.54
Dividend Yield0%
ROCE0.48%
ROE10.59%
Debt to Equity0.17
Current Ratio5.62
P/B Ratio1.3765035
EPS$ 27.85
Debt$1.20B
PAT Margin29.42%
Cash PAT$925.30M
ICR0.96